The emerging patent landscape of CRISPR-Cas gene editing technology.
Nature biotechnology, 34(10): 1025-1031 PMID 27727218 DOI 10.1038/nbt.3692
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.
Nature biotechnology, 34(10): 1025-1031 PMID 27727218 DOI 10.1038/nbt.3692
This article has no abstract in PubMed.